Based on the literature, not just the tumor cells but the tumor-associated and normal stroma cells can also modify the differentiation of moDCs in the presence of IL-4 and GM-CSF, resulting in upregulated expression of DC-SIGN [41, 42]. This evidence concerns the gene CD209 and neoplasm.